From building blocks of proteins to drugs: A quantum chemical study on structure-property relationships of phenylalanine, tyrosine and dopa
AI-generated Key Points
⚠The license of the paper does not allow us to build upon its content and the key points are generated using the paper metadata rather than the full article.
- The study investigated the impact of hydroxyl (OH) group substitutions on the physico-chemical properties of levodopa (L-dopa), phenylalanine, and tyrosine using density functional theory and ab initio methods.
- L-dopa is an important therapeutic drug for Parkinson's disease and shares structural homology with amino acids, whose structures differ only by OH substitutions in their phenyl side chains.
- While the backbone geometries of the aromatic molecules did not show any significant differences due to OH groups, their other molecular-level properties such as molecular dipole moment, electronic properties, and aromaticity changed significantly.
- Binding energies of modified C 1s sites in the molecules shifted as much as 1.8 eV whereas electronic changes in their O 1s spectra occurred in higher energy regions (ca. 536 eV).
- Valence spectra provided enhanced insights into reactivity and chemical properties of aromatic molecules.
- Of the three molecules studied, L-dopa had the least HOMO-LUMO energy gap which readily explained its proactivity as a drug compound.
- Nuclear independent chemical shift calculations suggested that L-dopa also had more aromaticity features than those of amino acids.
- Overall, OH groups played a more prominent role in shaping physico-chemical properties of L-dopa which significantly improved its drug potency compared to phenylalanine and tyrosine.
- This study provides valuable insights into structure-property relationships between building blocks of proteins and drugs for future research endeavors aimed at developing novel therapeutic agents for various diseases.
Authors: Aravindhan Ganesan, Narges Mohammadi, Feng Wang
Abstract: Density functional theory and ab initio methods have been employed to address the impacts of hydroxyl (OH) group substitutions on the physico-chemical properties of levodopa (or L-dopa) against the natural amino acids, phenylalanine and tyrosine. L-dopa, which is an important therapeutic drug for Parkinson's disease, shares structural homology with the amino acids, whose structures differ only by OH substitutions in their phenyl side chains. It is revealed that the backbone geometries of the aromatic molecules do not show apparent OH-dependent differences; however, their other molecular-level properties, such as molecular dipole moment, electronic properties and aromaticity, change significantly. The core binding energy spectra indicate that the atom sites that undergo modifications exhibit large energy shifts, so as to accommodate the changes in the intra-molecular chemical environment of the molecules. The binding energies of the modified C 1s sites in the molecules shift as much as 1.8 eV, whereas the electronic changes in their O 1s spectra happen in the higher energy region (ca. 536 eV). The valence spectra provide enhanced insights on the reactivity and chemical properties of the aromatic molecules. The impacts of OH moieties on the valence spectra are predominantly focussed in the energy band<16 eV, where the frontier molecular orbitals display much reorganization and energy shifts from the amino acids to L-dopa. Of the three molecules, L-dopa also has the least HOMO-LUMO energy gap, which can readily explain its proactivity as a drug compound. Furthermore, the nuclear independent chemical shift calculations suggest that L-dopa also has more aromaticity features than those of the amino acids. The OH groups, therefore, play a more prominent role in shaping the physico-chemical properties of L-dopa, which significantly improve its drug potency.
Ask questions about this paper to our AI assistant
You can also chat with multiple papers at once here.
⚠The license of the paper does not allow us to build upon its content and the AI assistant only knows about the paper metadata rather than the full article.
Welcome to our AI assistant! Here are some important things to keep in mind:
- The assistant will only answer questions related to this specific paper.
- Please note that this is not a bot for casual chatting.
- If you want the answer in a language other than the language you chose for navigating the website, simply add "TRANSLATE IN LANGUAGE L" at the end of your query (replace "LANGUAGE L" with the language of your choice).
- For example, you could ask "Can you extract the most important aspect of the paper? TRANSLATE IN SPANISH".
- If you want to keep the history of your questions/answers you should create an account.
Assess the quality of the AI-generated content by voting
Why do we need votes?
Votes are used to determine whether we need to re-run our summarizing tools. If the count reaches -10, our tools can be restarted.
Similar papers summarized with our AI tools
Navigate through even more similar papers through atree representation
Look for similar papers (in beta version)
By clicking on the button above, our algorithm will scan all papers in our database to find the closest based on the contents of the full papers and not just on metadata. Please note that it only works for papers that we have generated summaries for and you can rerun it from time to time to get a more accurate result while our database grows.
Disclaimer: The AI-based summarization tool and virtual assistant provided on this website may not always provide accurate and complete summaries or responses. We encourage you to carefully review and evaluate the generated content to ensure its quality and relevance to your needs.